CDR Tickets

Issue Number 4690
Summary [DIS] Drug type element - schema change
Created 2019-10-30 15:58:42
Issue Type Improvement
Submitted By Juthe, Robin (NIH/NCI) [E]
Assigned To Kline, Bob (NIH/NCI) [C]
Status Closed
Resolved 2020-09-15 16:35:28
Resolution Fixed
Path /home/bkline/backups/jira/ocecdr/issue.251853
Description

As discussed in a previous meeting, we would like to add a new element to the DIS schema to store information about the drug class. We will likely want to have a controlled set of values reflecting either structural or functional classification, but these values are TBD.

Comment entered 2020-09-03 07:58:15 by Kline, Bob (NIH/NCI) [C]

Awaiting requirements.

Comment entered 2020-09-09 16:36:47 by Juthe, Robin (NIH/NCI) [E]

We'd like to add a new element called "Drug Type" to the DIS schema following the FDA Approval element. It should be multiply occurring and have a defined list of values. Here's the list:

  1. Chemotherapy

  2. Hormone therapy

  3. Immunotherapy

  4. Targeted therapy

  5. Radiotherapeutic

  6. Supportive care therapy

  7. Antiangiogenesis agent

  8. Cancer treatment vaccine

  9. Cancer prevention vaccine

  10. CAR T-cell therapy

  11. Enzyme inhibitor

  12. Immune checkpoint inhibitor

  13. Monoclonal antibody

  14. Small-molecule drug

  15. Other

Comment entered 2020-09-15 16:35:28 by Kline, Bob (NIH/NCI) [C]

Installed on DEV.

Comment entered 2020-10-09 12:14:30 by Osei-Poku, William (NIH/NCI) [C]

Verified on DEV. Thanks!

Comment entered 2020-11-04 10:45:56 by Osei-Poku, William (NIH/NCI) [C]

Verified on QA. Thanks!

Comment entered 2020-12-16 14:22:14 by Osei-Poku, William (NIH/NCI) [C]

Verified on PROD. Thanks!

Elapsed: 0:00:00.001398